title: Shedding light on FGF21: A potential negative regulator of PCSK9.
authors.affiliation: Department of Internal Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, PR China.
authors.forename: Yuan
authors.initials: Y
authors.lastname: Guo
authors.affiliation: Department of Internal Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, PR China.
authors.forename: Qiong
authors.initials: Q
authors.lastname: Liu
authors.affiliation: Department of Internal Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, 410011, PR China. Electronic address: xudanyan02@sina.com.
authors.forename: Danyan
authors.initials: D
authors.lastname: Xu
mesh_terms: D000818:Animals; D008078:Cholesterol, LDL / Q000097:blood; D005346:Fibroblast Growth Factors / Q000378:metabolism*; D006801:Humans; D008099:Liver / Q000378:metabolism; D009154:Mutation; D000091362:PCSK9 Inhibitors; D000071449:Proprotein Convertase 9 / Q000235:genetics / Q000378:metabolism*; D011973:Receptors, LDL / Q000378:metabolism
chemical_list: D008078:Cholesterol, LDL; C573412:LDLR protein, human; D000091362:PCSK9 Inhibitors; D011973:Receptors, LDL; C414620:fibroblast growth factor 21; D005346:Fibroblast Growth Factors; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9
keywords: FGF21; Low-density lipoprotein cholesterol; Low-density lipoprotein receptor; PCSK9; SREBP2